Li Fu Jun - Net Worth and Insider Trading
Li Fu Jun Net Worth
The estimated net worth of Li Fu Jun is at least $2 Million dollars as of 2024-06-23. Li Fu Jun is the Director of Zhuzhou Qianjin Pharmaceutical Co Ltd and owns about 224,365 shares of Zhuzhou Qianjin Pharmaceutical Co Ltd (SHSE:600479) stock worth over $2 Million. Details can be seen in Li Fu Jun's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Li Fu Jun has not made any transactions after 2018-06-15 and currently still holds the listed stock(s).
Transaction Summary of Li Fu Jun
Li Fu Jun Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Li Fu Jun owns 1 companies in total, including Zhuzhou Qianjin Pharmaceutical Co Ltd (SHSE:600479) .
Click here to see the complete history of Li Fu Jun’s form 4 insider trades.
Insider Ownership Summary of Li Fu Jun
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600479 | Zhuzhou Qianjin Pharmaceutical Co Ltd | 2018-06-15 | Director |
Li Fu Jun Latest Holdings Summary
Li Fu Jun currently owns a total of 1 stock. Li Fu Jun owns 224,365 shares of Zhuzhou Qianjin Pharmaceutical Co Ltd (SHSE:600479) as of June 15, 2018, with a value of $2 Million.
Latest Holdings of Li Fu Jun
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600479 | Zhuzhou Qianjin Pharmaceutical Co Ltd | 2018-06-15 | 224,365 | 10.44 | 2,342,371 |
Holding Weightings of Li Fu Jun
Li Fu Jun Form 4 Trading Tracker
According to the SEC Form 4 filings, Li Fu Jun has made a total of 0 transactions in Zhuzhou Qianjin Pharmaceutical Co Ltd (SHSE:600479) over the past 5 years. The most-recent trade in Zhuzhou Qianjin Pharmaceutical Co Ltd is the sale of 37,394 shares on June 15, 2018, which brought Li Fu Jun around $0.
Insider Trading History of Li Fu Jun
- 1
Li Fu Jun Trading Performance
GuruFocus tracks the stock performance after each of Li Fu Jun's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Li Fu Jun is -9.19%. GuruFocus also compares Li Fu Jun's trading performance to market benchmark return within the same time period. The performance of stocks bought by Li Fu Jun within 3 months outperforms 0 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Li Fu Jun's insider trading performs compared to the benchmark.
Performance of Li Fu Jun
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.87 | | | | | |
| Relative Return to S&P 500(%) | -11.04 | | | | | |
Li Fu Jun Ownership Network
Li Fu Jun Owned Company Details
What does Zhuzhou Qianjin Pharmaceutical Co Ltd do?
Who are the key executives at Zhuzhou Qianjin Pharmaceutical Co Ltd?
Li Fu Jun is the Director of Zhuzhou Qianjin Pharmaceutical Co Ltd. Other key executives at Zhuzhou Qianjin Pharmaceutical Co Ltd include senior management Liu Jian Wu , Supervisors Lv Fang Yuan , and Supervisors Zhang Shun Li .
Zhuzhou Qianjin Pharmaceutical Co Ltd (SHSE:600479) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Zhuzhou Qianjin Pharmaceutical Co Ltd (SHSE:600479) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zhuzhou Qianjin Pharmaceutical Co Ltd (SHSE:600479) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Zhuzhou Qianjin Pharmaceutical Co Ltd (SHSE:600479)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zhuzhou Qianjin Pharmaceutical Co Ltd Insider Transactions
Li Fu Jun Mailing Address
Above is the net worth, insider trading, and ownership report for Li Fu Jun. Currently GuruFocus does not have mailing address information for Li Fu Jun.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
